167 related articles for article (PubMed ID: 18483257)
21. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.
Leivonen SK; Mäkelä R; Ostling P; Kohonen P; Haapa-Paananen S; Kleivi K; Enerly E; Aakula A; Hellström K; Sahlberg N; Kristensen VN; Børresen-Dale AL; Saviranta P; Perälä M; Kallioniemi O
Oncogene; 2009 Nov; 28(44):3926-36. PubMed ID: 19684618
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
Travaglini L; Vian L; Billi M; Grignani F; Nervi C
Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
[TBL] [Abstract][Full Text] [Related]
23. The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells.
Wang C; Mayer JA; Mazumdar A; Brown PH
Breast Cancer Res Treat; 2012 Jun; 133(2):487-500. PubMed ID: 21947652
[TBL] [Abstract][Full Text] [Related]
24. Dysfunction of the RET receptor in human cancer.
Santoro M; Carlomagno F; Melillo RM; Fusco A
Cell Mol Life Sci; 2004 Dec; 61(23):2954-64. PubMed ID: 15583857
[TBL] [Abstract][Full Text] [Related]
25. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
[TBL] [Abstract][Full Text] [Related]
26. Regulation of c-Ret in the developing kidney is responsive to Pax2 gene dosage.
Clarke JC; Patel SR; Raymond RM; Andrew S; Robinson BG; Dressler GR; Brophy PD
Hum Mol Genet; 2006 Dec; 15(23):3420-8. PubMed ID: 17047028
[TBL] [Abstract][Full Text] [Related]
27. Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
Peters AA; Buchanan G; Ricciardelli C; Bianco-Miotto T; Centenera MM; Harris JM; Jindal S; Segara D; Jia L; Moore NL; Henshall SM; Birrell SN; Coetzee GA; Sutherland RL; Butler LM; Tilley WD
Cancer Res; 2009 Aug; 69(15):6131-40. PubMed ID: 19638585
[TBL] [Abstract][Full Text] [Related]
28. Leptin signaling in breast cancer: an overview.
Cirillo D; Rachiglio AM; la Montagna R; Giordano A; Normanno N
J Cell Biochem; 2008 Nov; 105(4):956-64. PubMed ID: 18821585
[TBL] [Abstract][Full Text] [Related]
29. Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance.
Plaza-Menacho I; Morandi A; Robertson D; Pancholi S; Drury S; Dowsett M; Martin LA; Isacke CM
Oncogene; 2010 Aug; 29(33):4648-57. PubMed ID: 20531297
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
31. Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy.
Spanheimer PM; Cyr AR; Gillum MP; Woodfield GW; Askeland RW; Weigel RJ
Ann Surg; 2014 Apr; 259(4):793-9. PubMed ID: 24045439
[TBL] [Abstract][Full Text] [Related]
32. Quantitative analysis of the activation mechanism of the multicomponent growth-factor receptor Ret.
Schlee S; Carmillo P; Whitty A
Nat Chem Biol; 2006 Nov; 2(11):636-44. PubMed ID: 17013378
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of Sef, an inhibitor of receptor tyrosine kinase signaling, is common to a variety of human carcinomas.
Zisman-Rozen S; Fink D; Ben-Izhak O; Fuchs Y; Brodski A; Kraus MH; Bejar J; Ron D
Oncogene; 2007 Sep; 26(41):6093-8. PubMed ID: 17420726
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress pathways highlighted in tumor cell immortalization: association with breast cancer outcome.
Dairkee SH; Nicolau M; Sayeed A; Champion S; Ji Y; Moore DH; Yong B; Meng Z; Jeffrey SS
Oncogene; 2007 Sep; 26(43):6269-79. PubMed ID: 17471242
[TBL] [Abstract][Full Text] [Related]
35. Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer.
Zheng ZZ; Xia L; Hu GS; Liu JY; Hu YH; Chen YJ; Peng JY; Zhang WJ; Liu W
Nucleic Acids Res; 2022 Oct; 50(18):10230-10248. PubMed ID: 36124682
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic relevance of overexpressed NOK mRNA in breast cancer.
Moriai R; Kobayashi D; Amachika T; Tsuji N; Watanabe N
Anticancer Res; 2006; 26(6C):4969-73. PubMed ID: 17214372
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of RET mediated cell proliferation in vitro by the kinase inhibitor SPP86.
Alao JP; Michlikova S; Dinér P; Grøtli M; Sunnerhagen P
BMC Cancer; 2014 Nov; 14():853. PubMed ID: 25409876
[TBL] [Abstract][Full Text] [Related]
38. The proliferative effects of 5-androstene-3 beta,17 beta-diol and 5 alpha-dihydrotestosterone on cell cycle analysis and cell proliferation in MCF7, T47D and MDAMB231 breast cancer cell lines.
Aspinall SR; Stamp S; Davison A; Shenton BK; Lennard TW
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):37-51. PubMed ID: 15026082
[TBL] [Abstract][Full Text] [Related]
39. Reciprocal feedback regulation of ST3GAL1 and GFRA1 signaling in breast cancer cells.
Fan TC; Yeo HL; Hsu HM; Yu JC; Ho MY; Lin WD; Chang NC; Yu J; Yu AL
Cancer Lett; 2018 Oct; 434():184-195. PubMed ID: 30040982
[TBL] [Abstract][Full Text] [Related]
40. Establishment and characterisation of two novel breast cancer cell lines.
Raju Bagadi SA; Kaur J; Ralhan R
Cell Biol Int; 2008 Jan; 32(1):55-65. PubMed ID: 17959394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
